Ono Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
3.12 | 31.91 | -90.21% | 6.89 | -54.7% |
| P/S |
|
0.7949 | 3.22 | -75.35% |
|
|
| P/BV |
|
0.5003 | 3.26 | -84.64% |
|
|
| P/FCF |
|
0.1034 | 19.77 | -99.48% |
|
|
| Ev/Ebitda |
|
1.36 | 10.21 | -86.7% |
|
|
| Ev/S |
|
0.482 | 1.89 | -74.45% |
|
|
| Ev/FCF |
|
2.7 | 17.78 | -84.83% |
|
|
| E/P |
|
13.78 | 1.47 | 838.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
35.5 | 24.68 | 43.86% | 36.36 | -2.37% |
| ROE |
|
16.68 | 13.16 | 26.72% |
|
|
| ROA |
|
14.25 | 6.08 | 134.24% |
|
|
| ROIC |
|
19.96 | 15.56 | 28.28% |
|
|
| ROS |
|
25.46 | 12.42 | 104.94% |
|
|
| ROCE |
|
20.07 | 15.07 | 33.21% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0497 | 6.27 | -99.21% | 0.06 | -17.23% |
| Nеt Debt/Ebitda |
|
-0.8814 | -5.69 | -84.51% |
|
|
| Debt/Ratio |
|
0.0097 | 0.2171 | -95.53% |
|
|
| Debt/Equity |
|
0.0967 | 12.61 | -99.23% |
|
|
| Debt/Net Income |
|
0.0692 | 15.13 | -99.54% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.73 | -100% | 2.55 | -100% |
| Number of years of dividend growth |
|
1 | 1.3 | -22.83% | ||
| DSI |
|
0.7857 | 0.7924 | -0.8443% |
|
|
| Average dividend growth |
|
5.41 | -247.24 | -102.19% |
|
|
| Average percentage for 5 years |
|
2.55 | 2.81 | -9.27% |
|
|
| Average percentage for payments |
|
56.27 | 247.93 | -77.3% |
|
|
| Difference from average difference in sector |
|
-1.73 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
71.9 | 96.77 | -25.7% | ||
| Growth impulse Ebitda in 5 years |
|
88.31 | 78.13 | 13.03% | ||
| Growth impulse Net Income in 5 years |
|
114.35 | 88.81 | 28.76% | ||
| Growth impulse FCF in 5 years |
|
73.71 | 62.73 | 17.5% | ||
| Growth impulse EPS in 5 years |
|
124.9 | 165.65 | -24.6% |
IP Score
7.99/10
